Peptide-based cancer therapeutics have earned the attention of the biomedical community over the course of the past two decades. From laboratory use to successful clinical trials, peptides enjoy the benefits of being small molecules, with low toxicity and the advantage of millions of years of evolution within their hosts. For a complete list of our cancer research peptides, please read our Cancer Peptide Brochure.